Medical News

RESPECT Trial: Trastuzumab, An Option for Adjuvant Therapy in Elderly HER2-positive Breast Cancer Patients

RESPECT trial is a randomized control trial investigating benefits of trastuzumab (H) monotherapy as an adjuvant treatment compared to the standard...

18 Jun, 2018

Email this page
Prognostic Factor for Survival in Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate

A study evaluated the outcomes of patients with castration-resistant prostate cancer (CRPC) who received treatment with abiraterone acetate (AA) in...

14 Jun, 2018

Email this page
Aromatase Inhibitor plus OFS Increase Freedom from Distance Recurrence in High-Risk Premenopausal Women with Breast Cancer

According to a new data presented at a recent ASCO 2018 conference, premenopausal women with HR+/HER2- breast cancer (BC) with high risk of...

13 Jun, 2018

Email this page
IAAM Alone, An Alternative Therapeutic Option for PCa Patients with PSM after RP

Prostate cancer (PCa) is one of the most common cancers in men. The National Comprehensive Cancer Network guideline recommends external beam...

08 Jun, 2018

Email this page

Our Publications

Pomalong (Pomalidomide) Monograph

Pomalidomide-dexamethasone is a standard of care in patients with relapsed/refractory multiple myeloma following exhaustion of treatment options.

Q & A on Imatinib- Focused on CML

Imatinib, a tyrosine kinase inhibitor, induces durable responses in the majority of CML patients and is currently the standard of care for CML. This...

Q & A on Imatinib- Focused on GIST

Imatinib,a tyrosine kinase inhibitor, has been demonstrated to be effective in the treatment of unresectable or metastatic GISTs by inhibition of...


This publication covers the key trials on rituximab in the treatment of various lymphomas.

Slide Library

Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

Email this page
Clinical Appraisal of Abiraterone acetate in Management of CRPC

Prostate cancer has become a major public health burden worldwide. Castration or hormonal therapy is the mainstay of treatment for the management of...

Email this page
HBV Reactivation in Patients Undergoing Chemotherapy

The risk of hepatitis B virus (HB) reactivation is high in patients receiving chemotherapy for solid or hematological malignancies which may lead to...

Email this page
Lung Cancer

This slide set provides information on types of lung cancer,epidemiology, pathophysiology, risk factors/causes, clinical features, diagnosis,...

Email this page

Key Trials

LATITUDE Study: Abiraterone Plus Prednisone Might Be Clinically Beneficial in Men with Metastatic Castration-Sensitive Prostate Cancer

Combination of Abiraterone with ADT is highly efficacious in treating men with metastatic castration-sensitive prostate cancer with manageable...

ElderTac Study: Erlotinib, A Potential Palliative Treatment for Elderly Patients with Advanced NSCLC

This study assessed the effectiveness and tolerability of erlotinib in elderly patients with non-small-cell lung cancer (NSCLC) after ≥1 platinum-...

CREATE-X Trial: Adjuvant Capecitabine Safe and Effective in HER2-Negative Breast Cancer Patients

In CREATE -X trial, adjuvant capecitabine therapy demonstrated prolonged disease-free survival and overall survival in breast cancer patients.  

The CBC Trial: Sustained Reduction in Mortality with Two-year Adjuvant Tamoxifen in High-risk Breast Cancer Patients

This is the longest 40-year follow-up trial of tamoxifen in high –risk breast cancer patients, exhibiting a sustained reduction in mortality. 

Patient Education

All You Wanted to Know about Prostate Cancer

Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also...

Living with Leukemia/Lymphoma

Tips for patient with leukaemia and lymphoma are explained along with pictures for better understanding. 

All You Wanted to Know about Ovarian Cancer

Risk factors, signs & symptoms, factors known to reduce ovarian cancer, diagnosis, treatment options and how to reduce risk of ovarian cancer...

Myths and Facts about Cancer

Throughout the years there have been many cancer myths floating around. This article will help clear the myths related to cancer.


Explore >>

Currently there is no content under this category.


Your choice of drug in the first-line treatment of patients with metastatic colorectal cancer treatment (CRC)
50% (2 votes)
Tegafur uracil
0% (0 votes)
50% (2 votes)
Total votes: 4